tiprankstipranks
Trending News
More News >

June Sherie Almenoff Insider Profile

4 Followers
June Sherie Almenoff, Director at NeuBase Therapeutics, holds 1.99K shares in Tenax Therapeutics (Ticker: TENX), holds 4.17K shares in Avalo Therapeutics (Ticker: AVTX), holds 13.18K shares in Brainstorm Cell Therapeutics (Ticker: BCLI). Most recently, June Sherie Almenoff Bought ― shares of Tenax Therapeutics on Nov 19, 2025 for an estimated value of $14.93K.
tipranks
June Sherie Almenoff

June Sherie Almenoff
NeuBase Therapeutics (NBSE)
Director

Ranked #93,667 out of 105,219 Corporate Insiders

Profitable Transactions

43%
3 out of 7 Profitable Transactions

Average Return

-30.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$111K
72.27%
21.17%
6.56%
0.00%
0.00% Others
A breakdown of June Sherie Almenoff's holdings

Insider Roles

Avalo Therapeutics
(AVTX)
Director
Tenax Therapeutics
(TENX)
Director
Brainstorm Cell Therapeutics
(BCLI)
Director
9 Meters Biopharma
(NMTRQ)
COO and Chief Medical Officer
+1 other positions
Roles that June Sherie Almenoff holds in companies

Most Profitable Insider Trade

Stock:
Tenax Therapeutics
(TENX)
Rating:Informative Buy
Date:Nov 19, 2025 - Today
Return:+41.60%
The most profitable trade made by June Sherie Almenoff

June Sherie Almenoff's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NBSE
NeuBase Therapeutics
Feb 10, 2015
Informative Buy
40.50K
$12.78K
Brainstorm Cell Therapeutics
Dec 17, 2021
Director
Uninformative Buy
$7.29K
9 Meters Biopharma
Aug 28, 2018
COO and Chief Medical Officer
Informative Buy
6.89K
Tenax Therapeutics
Nov 19, 2025
Director
Informative Buy
14.93K
$23.50K
Avalo Therapeutics
Apr 01, 2025
Director
Uninformative Buy
26.79K
$80.21K
Actinium Pharmaceuticals
Director
FURX
Furiex Pharmaceuticals
Feb 06, 2014
Uninformative Sell
13.27M
List of latest transactions for each holding click on a transaction to see June Sherie Almenoff's performance on stock

June Sherie Almenoff insider profile FAQ

What is the percentage of profitable transactions made by June Sherie Almenoff?
The percentage of profitable transactions made by June Sherie Almenoff is 43%.
    What is the average return per transaction made by June Sherie Almenoff?
    The average return per transaction made by June Sherie Almenoff is -30.20%.
      What stocks does June Sherie Almenoff hold?
      June Sherie Almenoff holds: NBSE, BCLI, NMTRQ, TENX, AVTX, ATNM, FURX stocks.
        What was June Sherie Almenoff’s latest transaction?
        June Sherie Almenoff latest transaction was an Informative Buy of $14.93K.
          What was June Sherie Almenoff's most profitable transaction?
          June Sherie Almenoff’s most profitable transaction was an Informative Buy of TENX stock on November 19, 2025. The return on the trade was 41.60%.
            What is June Sherie Almenoff's role in NeuBase Therapeutics?
            June Sherie Almenoff's role in NeuBase Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.